|
Other Liabilities
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Apr. 30, 2013
|
|||||||||||||||||||||||||||||||||||||
| Other Liabilities Disclosure [Text Block] |
Note 6 – Other Liabilities Other liabilities consist of the following as of:
During the nine months ended April 30, 2013, the Company entered into a five year capital lease arrangement for lab equipment aggregating $768 and into various installment loans for lab and transportation equipment aggregating $288 for the Clinical Labs segment. Future minimum payments under the capital lease net of interest of $89 aggregates $689, including a short term debt portion of $149 included in other current liabilities. Future minimum payments under the installment loans aggregate $427, including a short term portion of $164 included in other current liabilities. |
||||||||||||||||||||||||||||||||||||